Quarterly report pursuant to Section 13 or 15(d)

Interim Segment Information (Tables)

v3.19.3
Interim Segment Information (Tables)
6 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Segment information
Segment information for the three and six months ended September 30, 2019, and 2018, is set forth below: 
 
 
Three months ended September 30, 2019
(in thousands)
 
IBW
 
ISM
 
CNS
 
Total
Revenue
 
$
2,618

 
$
2,646

 
$
2,305

 
$
7,569

Cost of revenue
 
2,205


1,604

 
2,181

 
5,990

Gross profit
 
413

 
1,042

 
124

 
1,579

Gross margin
 
15.8
%
 
39.4
%
 
5.4
%
 
20.9
%
Research and development
 
403

 
619

 
427

 
1,449

Segment profit
 
$
10

 
$
423

 
$
(303
)
 
130

Operating expenses:
 
 
 
 
 
 
 
 
Sales and marketing
 
 
 
 
 
 
 
2,259

General and administrative
 
 
 
 
 
 
 
1,249

Intangible amortization
 
 
 
 
 
 
 
308

Operating profit (loss)
 
 
 
 
 
 
 
(3,686
)
Other income, net
 
 
 
 
 
 
 
125

Income tax benefit (expense)
 
 
 
 
 
 
 

Net income (loss) from continuing operations
 
 
 
 
 
 
 
$
(3,561
)
 
 
 
 
 
 
 
 
 
 
 
Three months ended September 30, 2018
(in thousands)
 
IBW
 
ISM
 
CNS
 
Total
Revenue
 
$
3,646

 
$
2,646

 
$
3,814

 
$
10,106

Cost of revenue
 
1,954

 
1,224

 
2,735

 
5,913

Gross profit
 
1,692

 
1,422

 
1,079

 
4,193

Gross margin
 
46.4
%
 
53.7
%
 
28.3
%
 
41.5
%
Research and development
 
867

 
558

 
418

 
1,843

Segment profit
 
$
825

 
$
864

 
$
661

 
2,350

Operating expenses:
 
 
 
 
 
 
 
 
Sales and marketing
 
 
 
 
 
 
 
1,876

General and administrative
 
 
 
 
 
 
 
1,400

Intangible amortization
 
 
 
 
 
 
 
832

Operating profit (loss)
 
 
 
 
 
 
 
(1,758
)
Other income, net
 
 
 
 
 
 
 
165

Income tax benefit (expense)
 
 
 
 
 
 
 
(10
)
Net income (loss) from continuing operations
 
 
 
 
 
 
 
$
(1,603
)
 
 
Six months ended September 30, 2019
(in thousands)
 
IBW
 
ISM
 
CNS
 
Total
Revenue
 
$
5,541

 
$
5,741

 
$
5,289

 
$
16,571

Cost of revenue
 
4,156


3,120

 
4,470

 
11,746

Gross profit
 
1,385

 
2,621

 
819

 
4,825

Gross margin
 
25.0
%
 
45.7
%
 
15.5
%
 
29.1
%
Research and development
 
802

 
1,320

 
883

 
3,005

Segment profit
 
$
583

 
$
1,301

 
$
(64
)
 
1,820

Operating expenses:
 
 
 
 
 
 
 
 
Sales and marketing
 
 
 
 
 
 
 
4,591

General and administrative
 
 
 
 
 
 
 
2,613

Intangible amortization
 
 
 
 
 
 
 
616

Operating profit (loss)
 
 
 
 
 
 
 
(6,000
)
Other income, net
 
 
 
 
 
 
 
289

Income tax benefit (expense)
 
 
 
 
 
 
 
(7
)
Net income (loss)
 
 
 
 
 
 
 
$
(5,718
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six months ended September 30, 2018
(in thousands)
 
IBW
 
ISM
 
CNS
 
Total
Revenue
 
$
7,203

 
$
8,390

 
$
7,550

 
$
23,143

Cost of revenue
 
3,849

 
4,020

 
5,146

 
13,015

Gross profit
 
3,354

 
4,370

 
2,404

 
10,128

Gross margin
 
46.6
%

52.1
%
 
31.8
%
 
43.8
%
Research and development
 
1,389

 
1,127

 
759

 
3,275

Segment profit (loss)
 
$
1,965

 
$
3,243

 
$
1,645

 
6,853

Operating expenses:
 
 
 
 
 
 
 
 
Sales and marketing
 
 
 
 
 
 
 
4,013

General and administrative
 
 
 
 
 
 
 
2,934

Intangible amortization
 
 
 
 
 
 
 
1,822

Operating profit (loss)
 
 
 
 
 
 
 
(1,916
)
Other income, net
 
 
 
 
 
 
 
284

Income tax benefit (expense)
 
 
 
 
 
 
 
(10
)
Net income (loss)
 
 
 
 
 
 
 
$
(1,642
)